Banking & Benifits

The value of Cord Tissue over Bone Marrow
The Cord Tissue

Cord tissue, which refers to the connective tissue of the umbilical cord (not the cord blood inside of it) is an easily accessible source of stem cells when a baby is born. The type of umbilical cord stem cells that exist in great quantities in the tissue are called mesenchymal stem cells (MSCs). MSCs collected from umbilical cord tissue are genetically unique to your baby and family. Cord tissue is routinely discarded along with the placenta after birth. Parents-to-be who want to expand their baby’s options for future medical treatment should consider banking stem cells from their baby’s cord tissue. While MSCs are not currently being used for medical therapies, they are the subject of over 200 clinical trials. Research has indicated that MSCs hold the promise of being able to someday treat debilitating conditions such as heart disease, type 1 diabetes, lung cancer, Parkinson’s Disease, and injuries to bones and cartilage. Saving stem cells from cord tissue is one of the best first decisions you can make for your child’s future.

• Proliferative Properties
  Mesenchymal stem cells from the umbilical cord tissue are more proliferative; hence larger numbers can be obtained on expansion from small initial numbers.

• Multiple Dosages
  Laboratory techniques are now well developed, that allow obtaining unlimited numbers of purified mesenchymal precursor cells, and thereby make available these valuable stem cells therapeutic use more than once.

• Approaching regulatory approval
  Mesenchymal stem cells are now being used in over 100 clinical trials, including two phase III clinical trials. Ease in administration: Unlike other cell therapies these cells are administered through standard IV, like many of the other drugs that are given to patients.

• Safety
  These stem cells are well tolerated, with no patient deaths, no toxicity or any adverse side effects reported, thus providing for large-scale clinical use.